Results 291 to 300 of about 10,512,482 (403)

Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties

open access: yes
JEADV Clinical Practice, EarlyView.
Patricia Garbayo‐Salmons   +1 more
wiley   +1 more source

Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background The Crohn's Disease Exclusion Diet (CDED) offers a dietary means of inducing and maintaining remission for patients with Crohn's disease (CD). Descriptions of efficacy have emerged primarily from Israel, Europe, and Canada. Here, we offer real‐world experience, from a tertiary care center in the United States. Methods We conducted a
Mayah Greenfield   +5 more
wiley   +1 more source

Post-operative care of small bowel transplant recipients [PDF]

open access: yes, 1993
Abu-Elmagd, K   +4 more
core  

The Association of Pregnancy and Scurvy in Indigenous Women and Their Children From the Late Holocene in California (USA)

open access: yesInternational Journal of Osteoarchaeology, EarlyView.
ABSTRACT Limited evidence of nutritional deficiencies has been identified in bioarchaeological studies of Native California populations, although isotopic and ethnohistoric research provides evidence of regional, seasonal, and cultural variability in food shortages.
Alyson Caine   +3 more
wiley   +1 more source

Rapid Induction of Remission With Upadacitinib Followed by Cytomegalovirus Colitis in a Hospitalized Patient With Crohn's Disease. [PDF]

open access: yesACG Case Rep J
Herran R   +14 more
europepmc   +1 more source

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

open access: yesThe Lancet, 2017
S. Kugathasan   +42 more
semanticscholar   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

open access: yesObesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone   +3 more
wiley   +1 more source

Portacaval shunt in hyperlipidemia [PDF]

open access: yes, 1974
Chase, HP   +5 more
core  

Home - About - Disclaimer - Privacy